| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 71795-25-0 | Acetamide,N-[4-[[[[[(2-chlorophenyl)methyl]amino](2-propyn-1-ylimino)methyl]amino]sulfonyl]phenyl]-; Acetamide,N-[4-[[[[[(2-chlorophenyl)methyl]amino](2-propynylamino)methylene]amino]sulfonyl]phenyl]-(9CI) |  | C19H19ClN4O3S | 詳情 | 供應(yīng)商 | |
| 71795-34-1 | Acetamide,N-[4-[[[1-[(2-chlorophenyl)methyl]-5-methyl-1H-imidazol-2-yl]amino]sulfonyl]phenyl]-; Acetamide, N-(4-(((1-((2-chlorophenyl)methyl)-5-methyl-1H-imidazol-2-y l)amino)sulfonyl)phenyl)- |  | C19H19ClN4O3S | 詳情 | 供應(yīng)商 | |
| 649735-46-6 | 酪氨酸激酶抑制劑; 1-[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-5-甲基吡咯并[2,1-F][1,2,4]三嗪-6-基]氧基]-2- | 1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propan; 1-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol; Brivanib; Tyrosine Kinase Inhibitor; (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yloxy)propan-2-ol; 2-Propanol, 1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)oxy)-, (2R)-; Bms 540215; Bms540215; Unii-ddu33B674i |  | C19H19FN4O3 | 詳情 | 供應(yīng)商 |